ZVRA

Zevra Therapeutics, Inc. Common Stock

8.93

USD

ZVRA Earnings Reports

Positive Surprise Ratio

ZVRA beat 19 of 40 last estimates.

48%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

$28.61M

$0.05

Implied change from Q3 25 (Revenue/ EPS)

+9.78%

-600.00%

Implied change from Q4 24 (Revenue/ EPS)

+137.58%

-107.25%

Zevra Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, ZVRA reported earnings of -0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.03 USD, resulting in a 71.99% surprise. Revenue reached 26.06 million, compared to an expected 27.16 million, with a -4.04% difference. The market reacted with a -9.73% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of 0.05 USD, with revenue projected to reach 28.61 million USD, implying an decrease of -600.00% EPS, and increase of 9.78% in Revenue from the last quarter.

FAQ

What were Zevra Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Zevra Therapeutics, Inc. Common Stock reported EPS of -$0.01, beating estimates by 71.99%, and revenue of $26.06M, -4.04% below expectations.

How did the market react to Zevra Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -9.73%, changed from $10.07 before the earnings release to $9.09 the day after.

When is Zevra Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Zevra Therapeutics, Inc. Common Stock's next earnings report?

Based on 10 analysts, Zevra Therapeutics, Inc. Common Stock is expected to report EPS of $0.05 and revenue of $28.61M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.